Daiichi Sankyo

Seagen scores $41.8M in Enhertu patent case against Daiichi Sankyo
Fierce Pharma
Mon, 04/11/22 - 11:00 am
Seagen
Daiichi Sankyo
patents
breast cancer
Enhertu
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Pharmaforum
Mon, 02/21/22 - 10:35 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-low breast cancer
breast cancer
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Mon, 01/31/22 - 10:49 am
Daiichi Sankyo
COVID-19
vaccines
MRNA
Japan
DS-5670
Daiichi Sankyo shuts down Plexxikon subsidiary to streamline Enhertu, ADC development
Endpoints
Wed, 01/12/22 - 11:26 pm
Daiichi Sankyo
Plexxikon
Enhertu
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group
FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag
Pharmaforum
Thu, 12/23/21 - 11:53 am
Daiichi Sankyo
FDA
antibody-drug conjugate
lung cancer
HER3
patritumab deruxtecan
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
AstraZeneca
Daiichi Sankyo
Gilead Sciences
Trodelvy
triple negative breast cancer
Dato-DXd
Daiichi could be rewarded for persisting with Vanflyta
EP Vantage
Fri, 11/19/21 - 10:49 am
Daiichi Sankyo
Vanflyta
AML
Daiichi jettisons ADC after flunking early solid tumor test
Fierce Biotech
Fri, 10/29/21 - 10:34 am
Daiichi Sankyo
antibody-drug conjugate
GIST
DS-6157
solid tumors
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Merck
Keytruda
Xeris Biopharma
XeriJect
Evaxion Biotech
EVX-01
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
Enhertu nabs speedy FDA review for earlier use in breast cancer
Pharmaforum
Mon, 10/4/21 - 10:57 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
FDA
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
ESMO
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Roche
ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals
Fierce Biotech
Fri, 09/17/21 - 11:06 am
ESMO
Daiichi Sankyo
antibody-drug conjugate
DS-7300
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty
Endpoints
Fri, 07/23/21 - 10:57 am
Novartis
patents
Tafinlar
Plexxikon
Daiichi Sankyo
AstraZeneca, Daiichi Sankyo uncork new TNBC data for 2nd partnered ADC — and it's adding more heat under Gilead's Trodelvy
Endpoints
Sun, 05/9/21 - 10:58 pm
AstraZeneca
Daiichi Sankyo
TNBC
antibody-drug conjugate
Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches
Fierce Pharma
Wed, 03/31/21 - 10:53 pm
Daiichi Sankyo
Sanofi
vaccines
VN-0105
pertussis
drug manufacturing
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Fierce Biotech
Mon, 03/22/21 - 10:37 am
Daiichi Sankyo
MRNA
COVID-19
vaccines
Japan
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin

Pages